Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic SyndromePere Barba, Rodrigo Martino, Qin Zhou, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2015
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseRoni Tamari, Stephen S Chung, Esperanza B Papadopoulos, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid MalignanciesBarbara Spitzer, Ann A Jakubowski, Esperanza B Papadopoulos, et al.Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantationKatherine N DuHamel, Catherine E Mosher, Gary Winkel, et al.Blood Advances|July 23, 2021
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformationOscar B Lahoud, Sean M Devlin, Molly A Maloy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.Advances in Cell and Gene Therapy|November 7, 2022
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantationChristina Cho, Patrick Hilden, Scott T Avecilla, et al.Pageof 9